Answers are grounded in this paper and cite their sources.
Randomized trial shows smartphone messaging can improve cardiovascular risk factors in recent PCI patients, suggesting enhanced engagement is key.
BACKGROUND Cardiac rehabilitation (CR) improves outcomes after percutaneous coronary intervention (PCI), but participation remains suboptimal due to barriers such as distance, cost, and lack of referral. Mobile health (mHealth) interventions may enhance secondary prevention by improving accessibility and engagement. OBJECTIVE This study aimed to evaluate the clinical effectiveness and user acceptability of a patient-specific smartphone messaging application (AnSim) in improving cardiovascular (CV) risk factors among patients who recently underwent PCI. METHODS This was a single-blinded, 2-arm randomized controlled trial conducted at 2 hospitals in Korea. A total of 120 patients who underwent PCI within the prior month was randomly assigned (1:1) to receive either a smartphone-based message intervention via the AnSim app plus usual care (intervention group) or usual care alone (control group). The intervention comprised personalized educational and motivational messages tailored by behavioral stage and risk profile, delivered 6 times per week for 6 months. The primary outcome was change in blood pressure at 6 and 9 months. Secondary outcomes were changes in lipid profiles, HbA1c, BMI, smoking status, physical activity, and achievement of guideline-recommended risk factor targets. User acceptability was assessed via questionnaire. RESULTS There were no significant differences between groups in blood pressure or secondary endpoints at 6 or 9 months. However, within the intervention group, patients who read more messages (>median) showed greater health diary engagement and were more likely to meet ≥4 recommended CV risk factor targets at 9 months (69.0% vs. 19.2%, P <0.001). Patients with improved blood pressure at 9 months had read significantly more messages (110.3 vs 83.3 days, P = .02). Overall user satisfaction with the app was high, with 87% finding messages helpful and 81% expressing a desire to continue receiving them. CONCLUSIONS Although no significant between-group differences were found in primary outcomes, patients with higher message engagement demonstrated improved cardiovascular risk profiles and greater adherence to guideline-recommended targets. This suggests that individualized, theory-based mHealth interventions may be beneficial for motivated users and warrant further long-term study. CLINICALTRIAL Clinical Research Information Service (CRIS) KCT0002361; https://cris.nih.go.kr/cris INTERNATIONAL REGISTERED REPORT RR2-10.2196/23285
No takes yet. Share an insight, caveat, or question.
Lee et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: